image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Bovis

January 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BVS
  • Price:
  • 1154p
Although only a few months since highly rated Greg Fitzgerald took the reins as CEO, housebuilder Bovis has already shown operational improvement. Its update from 1 July to 10 November said it’s fully sold its targeted FY’17 completions. Pricing remains “robust” with increases in average selling prices likely, driven by changes in mix and an underlying increase in prices.It’s also on track to reduce costs and overheads to a maximum 5% of revenue from FY’18.Impressively, net cash is expected to be “at least £100m” at year end, well ahead of broker forecasts for around £54m, the outperformance driven by the disposal of its shared equity portfolio for £22m. For 20 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X